StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Eli Lilly and Company
NYSE:LLY
Sector
Location
Market Cap
USD 700.84 B
Share Price
USD 772.87
Avg Daily Volume
4,188,687
Change (1 day)
-1.00%
Change (1 year)
-15.49%
Change (YTD)
0.11%
Eli Lilly and Company Free Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD 487.20 M
Eli Lilly and Company Free Cash Flow is USD 487.20 M for the Trailing 12 Months (TTM) ending March 31, 2025, a -112.82% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.
-
Eli Lilly and Company Free Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD -3.80 B, a -200.37% change year over year.
-
Eli Lilly and Company Free Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 3.79 B, a -35.00% change year over year.
-
Eli Lilly and Company Free Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 5.82 B, a 4.66% change year over year.
-
Eli Lilly and Company Free Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 5.56 B, a 51.07% change year over year.
Competitors
AbbVie Inc.
USD 187.63
ABBV
-1.65
-0.87%
Roche Holding AG
USD 342.25
RO.SW
-5.82
-1.67%
AstraZeneca PLC
USD 138.95
AZN.L
-2.01
-1.43%
Merck & Co., Inc.
USD 80.90
MRK
-0.03
-0.04%
Amgen Inc.
USD 292.95
AMGN
-5.29
-1.77%
Pfizer Inc.
USD 25.24
PFE
-0.14
-0.55%
Gilead Sciences, Inc.
USD 111.78
GILD
+0.03
0.03%
Sanofi
USD 96.52
SAN.PA
-1.52
-1.55%
Bristol-Myers Squibb Company
USD 46.49
BMY
-0.43
-0.92%
Chugai Pharmaceutical Co., Ltd.
USD 47.25
4519.T
-1.65
-3.37%
GSK plc
USD 18.98
GSK.L
-0.18
-0.96%
Regeneron Pharmaceuticals, Inc.
USD 538.11
REGN
-9.25
-1.69%
Cencora, Inc.
USD 302.50
COR
+6.27
2.12%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.45
600276.SS
+0.11
1.52%
Takeda Pharmaceutical Company Limited
USD 29.99
4502.T
-0.22
-0.74%
Haleon plc
USD 5.05
HLN.L
-0.10
-2.03%
Daiichi Sankyo Company, Limited
USD 21.41
4568.T
-0.29
-1.33%
UCB SA
USD 198.91
UCB.BR
+0.11
0.06%
Hansoh Pharmaceutical Group Company Limited
USD 3.95
3692.HK
-0.02
-0.47%
Teva Pharmaceutical Industries Limited
USD 17.03
TEVA.TA
-0.12
-0.68%
Key Data
| Date | Free Cash Flow | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities |
|---|
Competitors
AbbVie Inc.
USD 187.63
ABBV
-1.65
-0.87%
Roche Holding AG
USD 342.25
RO.SW
-5.82
-1.67%
AstraZeneca PLC
USD 138.95
AZN.L
-2.01
-1.43%
Merck & Co., Inc.
USD 80.90
MRK
-0.03
-0.04%
Amgen Inc.
USD 292.95
AMGN
-5.29
-1.77%
Pfizer Inc.
USD 25.24
PFE
-0.14
-0.55%
Gilead Sciences, Inc.
USD 111.78
GILD
+0.03
0.03%
Sanofi
USD 96.52
SAN.PA
-1.52
-1.55%
Bristol-Myers Squibb Company
USD 46.49
BMY
-0.43
-0.92%
Chugai Pharmaceutical Co., Ltd.
USD 47.25
4519.T
-1.65
-3.37%
GSK plc
USD 18.98
GSK.L
-0.18
-0.96%
Regeneron Pharmaceuticals, Inc.
USD 538.11
REGN
-9.25
-1.69%
Cencora, Inc.
USD 302.50
COR
+6.27
2.12%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.45
600276.SS
+0.11
1.52%
Takeda Pharmaceutical Company Limited
USD 29.99
4502.T
-0.22
-0.74%
Haleon plc
USD 5.05
HLN.L
-0.10
-2.03%
Daiichi Sankyo Company, Limited
USD 21.41
4568.T
-0.29
-1.33%
UCB SA
USD 198.91
UCB.BR
+0.11
0.06%
Hansoh Pharmaceutical Group Company Limited
USD 3.95
3692.HK
-0.02
-0.47%
Teva Pharmaceutical Industries Limited
USD 17.03
TEVA.TA
-0.12
-0.68%